Literature DB >> 3812264

Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney.

R Loutzenhiser, M Epstein, C Horton.   

Abstract

The renal hemodynamic response to calcium entry blockade depends on the neural, hormonal and physiologic determinants influencing basal renal vascular tone. The effects of perfusion pressure per se on the renal vascular response of the rat kidney to diltiazem were evaluated using normal kidneys and hydronephrotic kidneys perfused extracorporally. In isolated perfused normal kidneys, diltiazem did not alter perfusate flow or glomerular filtration rate (GFR) when administered at a perfusion pressure of 100 mm Hg. In contrast, when diltiazem was administered at a perfusion pressure of 150 mm Hg, the calcium antagonists caused a striking increase in GFR, which was accompanied by an increase in renal perfusate flow. In the isolated perfused hydronephrotic rat kidney, elevation of perfusion pressure was associated with an increase in renal vascular resistance and a reduction in afferent arteriolar diameter. Diltiazem abolished the pressure-induced constriction of afferent arterioles and caused an increase in renal perfusate flow in hydronephrotic kidneys perfused at pressures above 100 mm Hg. These findings suggest that in the setting of increased renal perfusion pressure, diltiazem's effects on GFR are mediated in part by an inhibition of pressure-induced constriction of the afferent arteriole.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812264     DOI: 10.1016/0002-9149(87)90180-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Calcium entry blocker nicardipine inhibits sodium and inorganic phosphate reabsorption independent of renal circulation in dogs.

Authors:  F Goto; I Watanabe
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 3.  Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

4.  Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass.

Authors:  En Yin Lai; Maristela L Onozato; Glenn Solis; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

5.  Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus.

Authors:  P K Carmines; K Ohishi; H Ikenaga
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  The effect of two different calcium antagonists on the glomerular haemodynamics in the dog.

Authors:  J Heller; V Horácek
Journal:  Pflugers Arch       Date:  1990-03       Impact factor: 3.657

7.  Felodipine in the treatment of patients with severe hypertension and impaired renal function.

Authors:  R Larsson; M K Lindsjö; B Danielsson; U Bengtsson; J H Hardlund; P A Sjöström; D Elmfeldt; L Moberg
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

8.  Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response.

Authors:  Xuemei Wang; Kosuke Takeya; Philip I Aaronson; Kathy Loutzenhiser; Rodger Loutzenhiser
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21

9.  Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter.

Authors:  Edward W Inscho; Anthony K Cook; R Clinton Webb; Li-Ming Jin
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.